Experimental antiviral drug stopped coronavirus transmission in ferrets within 24 HOURS

An experimental oral antiviral drug completely suppressed coronavirus transmission within 24 hours, a new study suggests. The medications, called molnupiravir, prevents the virus from multiplying itself, therefore preventing it from spreading throughout the body. Researchers found the drug blocked ferrets infected with COVID-19 from spreading the disease to one another, but those not given the … Read more

Pfizer Inc signs multi-year deal to manufacture Gilead’s coronavirus antiviral remdesivir

Pfizer Inc signs multi-year deal to manufacture Gilead’s coronavirus antiviral remdesivir to boost production of the drug Pfizer Inc has signed a multi-year deal with Gilead Sciences Inc to manufacture and supply the antiviral remdesivir  The drug is the only one approved in the US to treat coronavirus patients by emergency use after it was … Read more

Self-cleaning, anti-viral coating kills coronavirus in seconds

Self-cleaning and anti-viral doorknobs that are able to kill the coronavirus in seconds could be a reality in the coming weeks.  Dr Felicity de Cogan of the University of Birmingham revealed today that engineers are creating surfaces capable of rapidly neutralising the SARS-CoV-2 virus.  Speaking at an online press conference, Dr de Cogan said the … Read more

Flu researchers say we should make a NEW antiviral to stop coronavirus

Flu researchers say we should make a NEW antiviral to prevent coronavirus from replicating throughout the body and stop focusing on repurposing old drugs Researchers looked an older treatment for the flu, Tamiflu, and a newer treatment, Xofluza, the first new type of flu drug in 20 years Xofluza limited the amount of time a … Read more

How much will remdesivir cost? Experts say even $10 may be too much for Gilead’s antiviral

Experts say even $10 is too much for the US-made antiviral drug approved to treat the novel coronavirus. Gilead Sciences’ medication, remdesivir, was shown to help reduce patients’ hospital stays over a placebo, in a clinical trial run by the National Institutes of Health. Last week, it became the first drug approved by the US … Read more

Coronavirus: £7 antiviral spray protects surfaces for 90 days

A new disinfectant spray can protect surfaces from coronavirus for up to 90 days by making it ‘inactive’ will be on sale in Hong Kong from just £7 next month. Researchers at the Hong Kong University of Science and Technology say the ‘smart spray’ works on a range of surface types including metal, plastic and fabric. … Read more

Coronavirus: Antiviral drug remdesivir performs well in trials

A trial of the antiviral drug remdesivir has produced ‘positive data’ for treating coronavirus patients, its maker, Gilead Sciences, said Wednesday.  Gilead announced the results of a clinical trial testing the drug, which was originally developed to treat Ebola patients, in people severely ill with coronavirus.  Half of the 397 patients, who were sick enough … Read more

Remdesivir anti-viral trial reports ‘rapid recoveries’ for severe hospitalised coronavirus patients

Remdesivir anti-viral trial reports ‘rapid recoveries’ for severe hospitalised coronavirus patients with ‘nearly all’ discharged within a week.    University of Chicago Medicine recruited 125 people with COVID-19 as part of Gilead Science’s clinical trials. Of those people, 113 had severe disease.  All the patients were been treated with daily infusions of remdesivir. Most of them … Read more

MIDAS SHARE TIPS: How’s this for herd immunity? Animal feed maker with an anti-viral additive

MIDAS SHARE TIPS: How’s this for herd immunity? Animal feed maker with an anti-viral additive By Joanne Hart, Financial Mail on Sunday Published: 21:56 BST, 4 April 2020 | Updated: 21:56 BST, 4 April 2020 Coronavirus has turned business as usual on its head. With the country in lockdown, millions of people on furlough and … Read more

Fujifilm begins final stage of human trials for its antiviral flu drug for coronavirus

A Japanese drug company has begun the final stages of human trials for its flu therapeutic for treating coronavirus, it announced Tuesday.  Fujifilm’s Toyama Chemical branch makes a drug called Avigan, which is approved in Japan for stopping the flu virus from replicating in the body.  Researchers with the company think it may well have … Read more